Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Clinical trial NCT05369208 · COMPLETED

Trial details

NCT number: NCT05369208
Sponsor: Sobi, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2022-06-15
Primary completion: 2024-01-17
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.